These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1495020)

  • 81. Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei.
    Ferone R
    J Biol Chem; 1970 Feb; 245(4):850-4. PubMed ID: 5418106
    [No Abstract]   [Full Text] [Related]  

  • 82. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.
    Ferone R; Burchall JJ; Hitchings GH
    Mol Pharmacol; 1969 Jan; 5(1):49-59. PubMed ID: 4392112
    [No Abstract]   [Full Text] [Related]  

  • 83. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The dihydrofolate reductase domain of rodent malarias: point mutations and pyrimethamine resistance.
    Cheng Q; Saul A
    Mol Biochem Parasitol; 1994 Jun; 65(2):361-3. PubMed ID: 7969277
    [No Abstract]   [Full Text] [Related]  

  • 85. Studies of Plasmodium falciparum dihydrofolate-reductase thymidylate synthase: potential advantages.
    Inselburg J; Bzik DJ; Gu H; Li WB; Horii T
    Prog Clin Biol Res; 1989; 313():29-43. PubMed ID: 2675115
    [No Abstract]   [Full Text] [Related]  

  • 86. Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
    Wagner CR; Benkovic SJ
    J Med Chem; 1992 Jul; 35(15):2912-5. PubMed ID: 1495020
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.